Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06260072
Status:
RECRUITING
Last Update Posted:
2024-02-16
First Post:
2024-02-06
Brief Title:
Magnesium and Riboflavin Treatment for Post-Concussion Headache
Sponsor:
University of Virginia
Organization:
University of Virginia
Study Overview
Official Title:
Magnesium and Riboflavin Treatment for Post-Concussion Headache
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion The participant will be randomized to either active magnesium and riboflavin capsules or placebo inert capsules The capsules will be taken once a day for 14 days The participant will also complete a short diary form for the 14 days and will have 3 follow up visits either by telephone or in person
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None